- Home
- ATNI vs SOPH Comparison
ATNI vs SOPH Comparison
Compare ATNI & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATNI | SOPH |
|---|---|---|
| Founded | 1987 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 392.6M | 367.7M |
| IPO Year | 1994 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ATNI | SOPH |
|---|---|---|
| Price | $26.89 | $4.96 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 61.8K | ★ 84.7K |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | ★ 4.10% | N/A |
| EPS Growth | ★ 34.29 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $727,975,000.00 | N/A |
| Revenue This Year | $3.12 | $23.09 |
| Revenue Next Year | $1.10 | $19.57 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $13.76 | $2.58 |
| 52 Week High | $30.45 | $5.70 |
Technical Indicators
Market Signals| Indicator | ATNI | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 51.06 | 56.70 |
| Support Level | $25.13 | $4.54 |
| Resistance Level | $28.46 | $5.30 |
| Average True Range (ATR) | 0.95 | 0.30 |
| MACD | -0.08 | -0.00 |
| Stochastic Oscillator | 50.92 | 63.01 |
Price Performance
Historical ComparisonAbout ATNI ATN International Inc.
ATN International Inc is a telecommunications and utilities company. The company provides digital infrastructure and communications services with a focus on rural and remote markets in the United States, and internationally, including Bermuda and the Caribbean region. Its operating segments comprise U.S. Telecom and International Telecom. The company earns revenue from its International telecommunication segment.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.